Item 2.02 Results of Operations and Financial Condition.
On
The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit Description Number 99.1 Press Release titled "ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update" datedFebruary 24, 2023 . 104 Cover Page Interactive Data File. The cover page XBRL tags are embedded within the inline XBRL document (contained in Exhibit 101).
--------------------------------------------------------------------------------
© Edgar Online, source